Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season

被引:21
作者
Felmingham, D
Robbins, MJ
Tesfaslasie, Y
Harding, I
Shrimpton, S
Grüneberg, RN
机构
[1] GR Micro Ltd, London NW1 3ER, England
[2] Micron Res Ltd, Marmont Priory Farm, Wisbech PE14 9AR, Cambs, England
[3] SmithKline Beecham Pharmaceut, Welwyn Garden City AL7 1EY, Herts, England
[4] UCL Hosp NHS Trust, Dept Clin Microbiol, London WC1E 6BD, England
关键词
D O I
10.1093/jac/41.3.411
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The antimicrobial susceptibility of 1078 isolates of Haemophilus influenzae, 348 Streptococcus pneumoniae and 258 Moraxella catarrhalis was determined. Overall 15.1% of H. influenzae produced beta-lactamase; 98.8% were susceptible to co-amoxiclav, 85.8% to cefaclor, 96% to clarithromycin and 100% to ciprofloxacin. The majority (94.2%) of M. catarrhalis produced beta-lactamase. The overall prevalence of low-level penicillin resistance (MIC = 0.12-1 mg/L) amongst isolates of S. pneumoniae was 3.4% and that of high-level resistance (MIC greater than or equal to 2 mg/L) was 3.7%. Most (96.3%) of the isolates of S. pneumoniae were susceptible to amoxycillin (MIC less than or equal to 0.5 mg/L), 96% to cefaclor (MIC less than or equal to 8 mg/L), 90.7% to clarithromycin (MIC less than or equal to 0.25 mg/L) and 89% to ciprofloxacin (MIC less than or equal to 1 mg/L).
引用
收藏
页码:411 / 415
页数:5
相关论文
共 10 条
[1]  
Baquero F., 1996, CLIN MICROBIOL INFEC, V1, p2S10, DOI [10.1111/j.1469-0691.1996.tb00185.x, DOI 10.1111/J.1469-0691.1996.TB00185.X]
[2]   Non-enzyme mediated beta-lactam resistance in Haemophilus influenzae [J].
Corkill, JE ;
Dove, W .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (06) :1109-1111
[3]   Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study [J].
Doern, GV ;
Brueggemann, AB ;
Pierce, G ;
Holley, HP ;
Rauch, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :292-297
[4]   ANTIBIOTIC-RESISTANCE - DO WE NEED NEW THERAPEUTIC APPROACHES [J].
FELMINGHAM, D .
CHEST, 1995, 108 (02) :S70-S78
[5]  
Felmingham D, 1996, J ANTIMICROB CHEMOTH, V38, P1
[6]   Antimicrobial susceptibility of community-acquired bacterial lower respiratory tract pathogens [J].
Felmingham, D ;
Robbins, MJ ;
Dencer, C ;
Nathwani, A ;
Gruneberg, RN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (04) :747-751
[7]   Results of the Alexander project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens [J].
Gruneberg, RN ;
Felmingham, D ;
Acar, J ;
Lemozy, J ;
Bauernfeind, A ;
Grimm, H ;
Schito, GC ;
Russo, G ;
Baquero, F ;
Louzao, JL ;
Gruneberg, R ;
Murphy, P ;
Neu, H ;
Berk, S ;
Pfaller, M ;
Sewell, D ;
Doern, G .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 25 (04) :169-181
[8]   CHARACTERIZATION OF NON-BETA-LACTAMASE-MEDIATED AMPICILLIN RESISTANCE IN HEMOPHILUS-INFLUENZAE [J].
MENDELMAN, PM ;
CHAFFIN, DO ;
STULL, TL ;
RUBENS, CE ;
MACK, KD ;
SMITH, AL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :235-244
[9]  
National Committee for Clinical Laboratory Standards, 1995, M100S6 NCCLS
[10]  
Wise R, 1996, J ANTIMICROB CHEMOTH, V38, P1103